OBIO
Orchestra BioMed Holdings, Inc. · Healthcare · Market cap $348.9M
Insiders sold $172K net in the last 90 days ·1 seller, 2 buyers· 3 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 2, 2026
Insider Buying
$280K
reported purchases (SEC code P)
Insider Selling
$353K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Oct 2, 2026
Sherman Darren
Orchestra BioMed Holdings, Inc. (OBIO) has 46 SEC Form 4 filings (54 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 5 insiders at Orchestra BioMed Holdings, Inc. reported 9 open-market purchases totaling $280K and 6 open-market sales totaling $353K. The most active filer is See Remarks Sherman Darren with 6 filings. Insiders have net sold $136K over the trailing 6 months. The most recent open-market filing is a sale of 15,000 shares by See Remarks Sherman Darren, dated Oct 1, 2026, worth $95K.
- Industry:Biotechnology
- CEO:David Hochman
- Employees:86
- HQ:New Hope, PA, US
- IPO:2020-08-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| See Remarks | Sale | 15,000 | $95K | Oct 2 | -2.4% | SEC ↗ | |
Hochman David PFirst in 3 months | See Remarks | Purchase | 10,000 | $48K | Sep 8 | +6.9% | SEC ↗ |
| See Remarks | Sale | 15,000 | $74K | Sep 2 | +17.3% | SEC ↗ | |
| See Remarks | Purchase | 2,000 | $11K | Aug 28 | +12.0% | SEC ↗ | |
| See Remarks | Sale | 15,000 | $61K | Aug 4 | +35.9% | SEC ↗ | |
| See Remarks | Sale | 15,000 | $64K | Jul 2 | +38.5% | SEC ↗ | |
Sherman DarrenFirst filing | See Remarks | Sale | 15,000 | $58K | Jun 2 | +48.5% | SEC ↗ |
| See Remarks | Purchase | 5,000 | $19K | Jun 2 | +48.5% | SEC ↗ | |
| Director | Purchase | 665 | $2K | May 20 | +45.9% | SEC ↗ | |
| See Remarks | Purchase | 5,000 | $19K | May 19 | +45.1% | SEC ↗ | |
Aryeh JasonFirst filing | Director | Purchase | 8,971 | $35K | May 19 | — | SEC ↗ |
Fain Eric SFirst filing | Director | Purchase | 20,000 | $83K | May 18 | — | SEC ↗ |
| Insider | Sale | 32 | $132 | Apr 29 | — | SEC ↗ | |
Hochman David PFirst in 4 months | See Remarks | Purchase | 10,000 | $43K | Mar 16 | — | SEC ↗ |
Hochman David PFirst filing | See Remarks | Purchase | 5,000 | $20K | Nov 17 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does OBIO have?
Orchestra BioMed Holdings, Inc. (OBIO) has 46 SEC Form 4 filings (54 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for OBIO?
The most recent Form 4 filing for OBIO on Tracefour is dated Oct 2, 2026.
Who is the most active insider at OBIO?
The most active SEC Form 4 filer at OBIO in the rolling window is See Remarks Sherman Darren, with 6 filings.
What is the net insider flow at OBIO over the last 6 months?
Over the trailing 180 days, insiders at OBIO have net sold $136K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at OBIO in the current window?
Inside the rolling window, insiders at OBIO bought $280K and sold $353K based on SEC Form 4 filings.
Can I get alerts for OBIO insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Orchestra BioMed Holdings, Inc. (OBIO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Orchestra BioMed Holdings, Inc. is in the Healthcare sector.